Bessemer Group’s Erasca ERAS Stock Holding History

Bessemer Group’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$26K	Hold	1,587	–	–	﹤0.01%	1855
2025 Q4	$6K	Buy	+1,587	New	+$4.46K	﹤0.01%	2218

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Bessemer Group's ERAS Position: Q1 2026 in Review

Bessemer Group held its Erasca (ERAS) position steady in Q1 2026 at 1,587 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Bessemer Group first reported a position in ERAS in Q4 2025 and has held it in 2 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

Bessemer Group held 1,587 shares of Erasca worth $26K as of Q1 2026.
Bessemer Group left its Erasca share count unchanged in Q1 2026.
Erasca made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #1855 holding.
Bessemer Group first reported a position in Erasca in Q4 2025 and has held it in 2 quarters since.
225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.